Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Argen-X | Bruxelles | Salute | Ricerca medica e biotecnologica | 38,37 Mrd € | -976,2x | -11,72 | 634,40 € | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,6% Rialzo | Fai l’upgrade a Pro+ | |
UCB | Bruxelles | Salute | Prodotti farmaceutici | 34,83 Mrd € | 146x | -5,22 | 183,15 € | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 12,2% Rialzo | Fai l’upgrade a Pro+ | |
Financiere Tubize | Bruxelles | Salute | Prodotti farmaceutici | 6,45 Mrd € | 73x | 144,40 € | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,7% Rialzo | Fai l’upgrade a Pro+ | ||
Fagron | Bruxelles | Salute | Prodotti farmaceutici | 1,34 Mrd € | 17,1x | 1,04 | 18,12 € | 6,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 24,5% Rialzo | Fai l’upgrade a Pro+ | |
Nyxoah | Bruxelles | Salute | Attrezzature e forniture medicali | 388,85 Mln € | -6,1x | 2,17 | 10,40 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 21,1% Rialzo | Fai l’upgrade a Pro+ | |
Ion Beam Applications | Bruxelles | Salute | Attrezzature e forniture medicali | 371,77 Mln € | 47,4x | 0,34 | 12,68 € | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 41,5% Rialzo | Fai l’upgrade a Pro+ | |
ONWARD Medical BV | Bruxelles | Salute | Attrezzature e forniture medicali | 269,56 Mln € | -4,7x | -0,82 | 6,24 € | 3,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hyloris | Bruxelles | Salute | Prodotti farmaceutici | 156,80 Mln € | -13,3x | 3,05 | 5,80 € | 3,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
AGFA Gevaert | Bruxelles | Salute | Attrezzature e forniture medicali | 119,21 Mln € | -3,5x | -0,04 | 0,77 € | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sequana Medical | Bruxelles | Salute | Ricerca medica e biotecnologica | 115,98 Mln € | -2,9x | -0,13 | 2,63 € | 2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Biocartis Group NV | Bruxelles | Salute | Attrezzature e forniture medicali | 27,24 Mln € | -0,3x | 0,29 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
European Medical Solutions | Bruxelles | Salute | Fornitori e servizi sanitari | 26,24 Mln € | -24,5x | 0,64 | 6,20 € | -7,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Celyad | Bruxelles | Salute | Ricerca medica e biotecnologica | 21,13 Mln € | -2,3x | -0,03 | 0,51 € | -1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Biosenic | Bruxelles | Salute | Prodotti farmaceutici | 1,89 Mln € | -0 | 0,005 € | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Oxurion | Bruxelles | Salute | Ricerca medica e biotecnologica | 836.820,01 € | 0,23 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Personalized Nursing Services | Bruxelles | Salute | Fornitori e servizi sanitari | 245.000 € | 0,40 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |